Patient and general practitioner experiences of implementing a medication review intervention in older people with multimorbidity: Process evaluation of the SPPiRE trial

The SPPiRE cluster randomized controlled trial found that a general practitioner (GP)‐delivered medication review that incorporated screening for potentially inappropriate prescriptions (PIP), a brown bag review and a patient priority assessment, resulted in a significant but small reduction in the number of medicines and no significant reduction in PIP. This process evaluation aims to explore the experiences of GPs and patients and the potential for system‐wide implementation.

[1]  E. Puigoriol-Juvanteny,et al.  Improving individualized prescription in patients with multimorbidity through medication review , 2022, BMC Geriatrics.

[2]  Susan M. Smith,et al.  GP-delivered medication review of polypharmacy, deprescribing, and patient priorities in older people with multimorbidity in Irish primary care (SPPiRE Study): A cluster randomised controlled trial , 2022, PLoS medicine.

[3]  Collette E. Kirwan,et al.  The MultimorbiditY COllaborative Medication Review And DEcision Making (MyComrade) study: a protocol for a cross-border pilot cluster randomised controlled trial , 2021, Pilot and Feasibility Studies.

[4]  P. Raina,et al.  Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial , 2021, Trials.

[5]  C. Codina-Jané,et al.  Improving medication adherence and effective prescribing through a patient-centered prescription model in patients with multimorbidity , 2021, European Journal of Clinical Pharmacology.

[6]  M. Fortin,et al.  Interventions for improving outcomes in patients with multimorbidity in primary care and community setting: a systematic review , 2021, Systematic Reviews.

[7]  Susan M. Smith,et al.  The evolution of an evidence based intervention designed to improve prescribing and reduce polypharmacy in older people with multimorbidity and significant polypharmacy in primary care (SPPiRE) , 2020, Journal of comorbidity.

[8]  P. Boland,et al.  Barriers and facilitators to deprescribing in primary care: a systematic review , 2020, BJGP open.

[9]  T. Fahey,et al.  Evaluation of the General Practice Pharmacist (GPP) intervention to optimise prescribing in Irish primary care: a non-randomised pilot study , 2019, BMJ Open.

[10]  B. Guthrie,et al.  Can implementation failure or intervention failure explain the result of the 3D multimorbidity trial in general practice: mixed-methods process evaluation , 2019, BMJ Open.

[11]  H. Noble,et al.  Triangulation in research, with examples , 2019, Evidence Based Journals.

[12]  M. Bouvy,et al.  Effects of a clinical medication review focused on personal goals, quality of life, and health problems in older persons with polypharmacy: A randomised controlled trial (DREAMeR-study) , 2019, PLoS medicine.

[13]  M. Tinetti,et al.  Evidence supporting the best clinical management of patients with multimorbidity and polypharmacy: a systematic guideline review and expert consensus , 2018, Journal of internal medicine.

[14]  Susan M. Smith,et al.  Study protocol for a process evaluation of a cluster randomised controlled trial to reduce potentially inappropriate prescribing and polypharmacy in patients with multimorbidity in Irish primary care (SPPiRE). , 2019, HRB open research.

[15]  P. Bower,et al.  Management of multimorbidity using a patient-centred care model: a pragmatic cluster-randomised trial of the 3D approach , 2018, The Lancet.

[16]  L. Uhlmann,et al.  Effectiveness of a complex intervention on Prioritising Multimedication in Multimorbidity (PRIMUM) in primary care: results of a pragmatic cluster randomised controlled trial , 2018, BMJ Open.

[17]  H. van den Bussche,et al.  Narrative medicine-based intervention in primary care to reduce polypharmacy: results from the cluster-randomised controlled trial MultiCare AGENDA , 2018, BMJ Open.

[18]  B. Guthrie,et al.  Process evaluation of the Data-driven Quality Improvement in Primary Care (DQIP) trial: case study evaluation of adoption and maintenance of a complex intervention to reduce high-risk primary care prescribing , 2017, BMJ Open.

[19]  M. Wensing,et al.  Impact of a tailored program on the implementation of evidence-based recommendations for multimorbid patients with polypharmacy in primary care practices—results of a cluster-randomized controlled trial , 2017, Implementation Science.

[20]  B. Guthrie,et al.  Process evaluation of the data-driven quality improvement in primary care (DQIP) trial: active and less active ingredients of a multi-component complex intervention to reduce high-risk primary care prescribing , 2017, Implementation Science.

[21]  U. Jaehde,et al.  Interprofessional Medication Management in Patients With Multiple Morbidities. , 2016, Deutsches Arzteblatt international.

[22]  S. Shakib,et al.  Development and Validation of the Revised Patients’ Attitudes Towards Deprescribing (rPATD) Questionnaire: Versions for Older Adults and Caregivers , 2016, Drugs & Aging.

[23]  C. O’Donnell,et al.  Learning from doing: the case for combining normalisation process theory and participatory learning and action research methodology for primary healthcare implementation research , 2016, BMC Health Services Research.

[24]  M. Tully,et al.  Nonmedical prescribing: where are we now? , 2016, Therapeutic advances in drug safety.

[25]  Bruce Guthrie,et al.  Safer Prescribing--A Trial of Education, Informatics, and Financial Incentives. , 2016, The New England journal of medicine.

[26]  Stewart W. Mercer,et al.  Improving medication management in multimorbidity: development of the MultimorbiditY COllaborative Medication Review And DEcision Making (MY COMRADE) intervention using the Behaviour Change Wheel , 2015, Implementation Science.

[27]  A. O’Cathain,et al.  Process evaluation of complex interventions: Medical Research Council guidance , 2015, BMJ : British Medical Journal.

[28]  C. Bradley,et al.  What to give the patient who has everything? A qualitative study of prescribing for multimorbidity in primary care. , 2015, The British journal of general practice : the journal of the Royal College of General Practitioners.

[29]  Paul Gallagher,et al.  STOPP/START criteria for potentially inappropriate prescribing in older people: version 2 , 2014, Age and ageing.

[30]  A. Sheikh,et al.  Description and process evaluation of pharmacists' interventions in a pharmacist-led information technology-enabled multicentre cluster randomised controlled trial for reducing medication errors in general practice (PINCER trial) , 2013, The International journal of pharmacy practice.

[31]  M. Wiese,et al.  Patient Barriers to and Enablers of Deprescribing: a Systematic Review , 2013, Drugs & Aging.

[32]  Bruce Guthrie,et al.  Process evaluations for cluster-randomised trials of complex interventions: a proposed framework for design and reporting , 2013, Trials.

[33]  B. Guthrie,et al.  Guidelines for people not for diseases: the challenges of applying UK clinical guidelines to people with multimorbidity. , 2013, Age and ageing.

[34]  E. Perrin,et al.  Guiding Principles for the Care of Older Adults with Multimorbidity: An Approach for Clinicians , 2012, Journal of the American Geriatrics Society.

[35]  A. Sheikh,et al.  A pharmacist-led information technology intervention for medication errors (PINCER): a multicentre, cluster randomised, controlled trial and cost-effectiveness analysis , 2012, The Lancet.

[36]  Martin Fortin,et al.  A Systematic Review of Prevalence Studies on Multimorbidity: Toward a More Uniform Methodology , 2012, The Annals of Family Medicine.

[37]  A. O’Cathain,et al.  Three techniques for integrating data in mixed methods studies , 2010, BMJ : British Medical Journal.

[38]  S. Dahrouge,et al.  Randomized controlled trial of anticipatory and preventive multidisciplinary team care: for complex patients in a community-based primary care setting. , 2009, Canadian family physician Medecin de famille canadien.

[39]  M. Petticrew,et al.  Developing and evaluating complex interventions: the new Medical Research Council guidance , 2008, BMJ : British Medical Journal.

[40]  Nick Barber,et al.  Appropriate prescribing in elderly people: how well can it be measured and optimised? , 2007, The Lancet.

[41]  V. Braun,et al.  Using thematic analysis in psychology , 2006 .

[42]  Felicity Smith,et al.  The roles of informal carers in the management of medication for older care‐recipients , 2002 .

[43]  J. Krska,et al.  Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. , 2001, Age and ageing.

[44]  Elizabeth DePoy,et al.  Introduction to Research: Understanding and Applying Multiple Strategies , 1998 .